Stay updated on Efficacy of Oral Ibrexafungerp vs. Placebo in VVC Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Oral Ibrexafungerp vs. Placebo in VVC Clinical Trial page.

Latest updates to the Efficacy of Oral Ibrexafungerp vs. Placebo in VVC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe clinical trial record for VANISH 306 is displayed, including its design, ibrexafungerp and placebo treatments, eligibility criteria, study outcomes, and locations.SummaryDifference65%

- Check18 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0 while the page continued to display a 403 error.SummaryDifference0.2%

- Check25 days agoChange DetectedA banner announces an NIH website transition and says that “Super Intelligence” may appear in place of “Artificial Intelligence” during the change.SummaryDifference1%

- Check32 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2. The study page still displays a 403 error.SummaryDifference0.2%

- Check39 days agoChange DetectedThe footer revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check60 days agoChange DetectedThe study page now shows a 403 Forbidden error, preventing access to the study details and indicating restricted viewing of the record.SummaryDifference18%

Stay in the know with updates to Efficacy of Oral Ibrexafungerp vs. Placebo in VVC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Oral Ibrexafungerp vs. Placebo in VVC Clinical Trial page.